Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs BHP Billiton Limited (BHP) Price & Performance

Amgen, Inc.Trade
BHP Billiton LimitedTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs BHP Billiton Limited — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while BHP Billiton Limited trades at $90.77 (market cap $229.15B). The key difference: Amgen, Inc. and BHP Billiton Limited are close in size by market cap, and BHP Billiton Limited pays the higher dividend (2.95%). Which is the better fit depends on your goals.

AMGNBHP
Market Cap
$224.14B$229.15B
Sector
HealthBasic Materials
52-Week High
$417.20$93.15
52-Week Low
$271.18$52.14
Enterprise Value
$267.45B$243.35B
Dividend Yield
2.43%2.95%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About BHP Billiton Limited

BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.

Read more on BHP